North America Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

North America Preclinical In-vivo Imaging Market By Modality (optical Imaging, Nuclear Imaging, Micro-MRI, Micro-CT, Micro-ultrasound, Photoacoustic, And Magnetic Particle Imaging Systems), By Reagent (optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents, And CT Contrast Agents), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)

ID: 583 | Pages: 140 | September 2016 | Region: North America


The North America Preclinical in-vivo imaging market has been estimated at USD 261.8 Million in 2016 and is projected to reach USD  346.4 Million by 2022, at a CAGR of 4.90% during the forecast period from 2016 to 2022. Preclinical in-vivo imaging modalities are very crucial for researchers in observing changes, either at the organ, tissue, cell, or molecular level, responding to physiological or environmental changes. It helps in gaining greater understanding of disease and therapeutic efficacy.

The factors such as development of technologically advanced hybrid preclinical imaging systems such as PET/CT, PET/MRI, and PET/SPECT/CT, and growing acceptance of preclinical imaging as a legitimate drug development tool are the driving the market for Preclinical in-vivo imaging in North America. Declining NIH (National Institutes of Health) funding for life science research is constraining the market growth in this region.

North America market for Preclinical In-vivo Imaging is segmented based on Modality and Reagents. Based on modality, the North America preclinical imaging market is divided into seven major segments, namely, optical imaging, nuclear imaging, micro-MRI, micro-CT, micro-ultrasound, photoacoustic, and magnetic particle imaging systems. The preclinical optical imaging systems market includes bioluminescence/fluorescence imaging systems, standalone fluorescence imaging systems, optical + X-ray/optical + CT imaging systems. The preclinical nuclear imaging systems market comprises micro-PET systems (standalone PET, PET/CT, and PET/MRI), micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI), and tri-modality (PET/SPECT/CT) imaging systems. Bases on the reagents, the North America preclinical imaging market is divided into five segments, namely, optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents market is further sub-segmented as bioluminescent and fluorescent imaging reagents. Likewise, the nuclear imaging reagents market is divided as preclinical PET tracers and SPECT robes.

Geographically, North America market for Preclinical In-vivo Imaging is segmented into U.S and Canada. North America holds the largest share of the global preclinical imaging market, while, U.S holds the maximum share in North America. The preclinical imaging market in North America is primarily driven by various factors like high volume of preclinical research in this region, easy availability and accessibility of resources, and rising government funding for research and innovation in Canada.

Aspect Imaging, Biospace Lab S.A., Bruker Corporation, LI-COR Biosciences, Mediso Ltd., MILabs B.V., MR Solutions Ltd, PerkinElmer, Inc., TriFoil Imaging, and FUJIFILM VisualSonics, Inc. are the key players operating in the North America preclinical imaging systems market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Modality                

                                5.1.1 Optical imaging      

                                                5.1.1.1 Bioluminescence/fluorescence imaging systems

                                                5.1.1.2 Standalone fluorescence imaging systems

                                                5.1.1.3 Optical + X-ray/optical + CT imaging systems

                                5.1.2 Nuclear imaging    

                                                5.1.2.1 Micro-PET systems (standalone PET, PET/CT, and PET/MRI)

                                                5.1.2.2 Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI)

                                                5.1.2.3 Tri-modality (PET/SPECT/CT) imaging systems

                                5.1.3 Micro-MRI               

                                5.1.4 Micro-CT  

                                5.1.5 Micro-ultrasound 

                                5.1.6 Photoacoustic        

                                5.1.7 Magnetic particle imaging systems               

                5.2 By Reagent                 

                                5.2.1 Optical imaging reagents   

                                                5.2.1.1 Bioluminescent reagents

                                                5.2.1.2 Fluorescent imaging reagents

                                5.2.2 Nuclear imaging reagents 

                                                5.2.2.1 Preclinical PET tracers

                                                5.2.2.2 Preclinical SPECT probes

                                5.2.3 MRI contrast agents            

                                5.2.4 Ultrasound contrast agents             

                                5.2.5 CT contrast agents               

6. Geographical Analysis                                              

                                6.1 Introduction               

                                6.2 United States            

                                6.3 Canada         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 Aspect Imaging                         

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues             

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Biospace Lab S.A.                     

                8.3 Bruker Corporation                 

                8.4 LI-COR Biosciences                  

                8.5 Mediso Ltd.                

                8.6 MILabs B.V.                

                8.7 MR Solutions Ltd                      

                8.8 PerkinElmer               

                8.9 TriFoil Imaging                           

                8.10 FUJIFILM VisualSonics, Inc.                                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Expert Opinions                                        

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Preclinical in-vivo imaging Market By Region, From 2016-2022 (USD Million)
  2. North America Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  3. North America Preclinical Optical imaging Market By Region, From 2016-2022 (USD Million)
  4. North America Preclinical Bioluminescence/fluorescence imaging systems Market By Region, From 2016-2022 (USD Million)
  5. North America Preclinical Standalone fluorescence imaging systems Market By Region, From 2016-2022 (USD Million)
  6. North America Preclinical Optical + X-ray/optical + CT imaging systems Market By Region, From 2016-2022 (USD Million)
  7. North America Preclinical Nuclear imaging Market By Region, From 2016-2022 (USD Million)
  8. North America Preclinical Micro-PET systems (standalone PET, PET/CT, and PET/MRI) Market By Region, From 2016-2022 (USD Million)
  9. North America Preclinical Micro-SPECT systems (standalone SPECT, SPECT/CT, and SPECT/MRI) Market By Region, From 2016-2022 (USD Million)
  10. North America Preclinical Tri-modality (PET/SPECT/CT) imaging systems Market By Region, From 2016-2022 (USD Million)
  11. North America Preclinical Micro-MRI Market By Region, From 2016-2022 (USD Million)
  12. North America Preclinical Micro-CT Market By Region, From 2016-2022 (USD Million)
  13. North America Preclinical Micro-ultrasound Market By Region, From 2016-2022 (USD Million)
  14. North America Preclinical Photoacoustic Market By Region, From 2016-2022 (USD Million)
  15. North America Preclinical Magnetic particle imaging systems Market By Region, From 2016-2022 (USD Million)
  16. North America Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  17. North America Preclinical Optical imaging reagents Market By Region, From 2016-2022 (USD Million)
  18. North America Preclinical Bioluminescent reagents Market By Region, From 2016-2022 (USD Million)
  19. North America Preclinical Fluorescent imaging reagents Market By Region, From 2016-2022 (USD Million)
  20. North America Preclinical Nuclear imaging reagents Market By Region, From 2016-2022 (USD Million)
  21. North America Preclinical PET tracers Market By Region, From 2016-2022 (USD Million)
  22. North America Preclinical SPECT probes Market By Region, From 2016-2022 (USD Million)
  23. North America Preclinical MRI contrast agents Market By Region, From 2016-2022 (USD Million)
  24. North America Preclinical Ultrasound contrast agents Market By Region, From 2016-2022 (USD Million)
  25. North America Preclinical CT contrast agents Market By Region, From 2016-2022 (USD Million)
  26. United States Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  27. United States Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  28. United States Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  29. United States Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  30. United States Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  31. United States Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
  32. Canada Preclinical in-vivo imaging Market By Modality, From 2016-2022 (USD Million)
  33. Canada Preclinical in-vivo imaging Market By Reagent, From 2016-2022 (USD Million)
  34. Canada Preclinical Optical Imaging Market By Optical imaging, From 2016-2022 (USD Million)
  35. Canada Preclinical Nuclear Imaging Market By Preclinical Nuclear imaging, From 2016-2022 (USD Million)
  36. Canada Preclinical Optical imaging reagents Market By Optical imaging reagents, From 2016-2022 (USD Million)
  37. Canada Preclinical Nuclear imaging reagents Market By Nuclear imaging reagents, From 2016-2022 (USD Million)
Middle East And Africa Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinar...
Latin America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Asia Pacific Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract In...
Europe Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infectio...
North America Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract I...
Virology Market By Type (Diagnosing Test, Viral Infection Controlling Methods, Antiviral Chemotherapy, Interferons) By Application (Skin And Soft Tissue Infections, GI Tract Infections, Urinary Tract Infection, Eye ...
Middle East And Africa Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competi...
Latin America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Asia Pacific Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mult...
Europe Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex,...
North America Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Mul...
Lateral Flow Assay Market By Product (Reader, Kit), Application (Clinical (Pregnancy, Infectious Disease, Lipid, Cardiac Marker), Veterinary, Drug Development, Food Safety), Technique (Competitive, Multiplex, Sandwi...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.